Effect of an RNAi therapeutic targeting PCSK9 on atherogenic lipoproteins: Pre-specified secondary endpoints in orion 1. (August 2018) - Ray, K.; Stoekenbroek, R.M.; Kallend, D.; Leiter, L.A.; Landmesser, U.; Scott-Wright, R.; Wijngaard, P.; Kastelein, J.J.P.